DUBLIN, Jan. 4, 2021 /PRNewswire/ -- Jazz Pharmaceuticals
plc (Nasdaq: JAZZ) today announced that the company will webcast
its corporate presentation at the 39th Annual J.P.
Morgan Healthcare Conference.
Bruce Cozadd, chairman and chief
executive officer, will provide an overview of the company and a
business and financial update on Monday,
January 11, 2021 at 2:00 p.m. EST / 7:00 p.m. GMT.
A live audio webcast of the presentation may be accessed from
the Investors section of the Jazz Pharmaceuticals website at
www.jazzpharmaceuticals.com. Please connect to the website
prior to the start of the presentation to ensure adequate time for
any software downloads that may be necessary to listen to the
webcast.
An archive of the webcast will be available following the
presentation for at least one week on the Investors section of the
company's website at www.jazzpharmaceuticals.com.
About Jazz Pharmaceuticals
Jazz Pharmaceuticals plc
(Nasdaq: JAZZ) is a global biopharmaceutical company dedicated to
developing and commercializing life-changing medicines that
transform the lives of patients with serious diseases — often with
limited or no options. We have a diverse portfolio of
marketed medicines and novel product candidates, from early- to
late-stage development, in key therapeutic areas. Our focus
is in neuroscience, including sleep and movement disorders, and in
oncology, including hematologic malignancies and solid tumors.
We actively explore new options for patients including novel
compounds, small molecule advancements, biologics and innovative
delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the
globe, serving patients in more than 90 countries. For more
information, please visit www.jazzpharmaceuticals.com and follow
@JazzPharma on Twitter.
Jazz
Pharmaceuticals Contacts:
|
|
Investors:
Kathee Littrell
Vice President, Investor Relations
Ireland +353 1 634 7887
U.S. +1 650 496 2717
|
Media:
Jacqueline Kirby
Vice President, Corporate Affairs & Government Relations
Ireland +353 1 697 2141
U.S. +1 215 867 4910
|
Logo -
https://mma.prnewswire.com/media/272253/Jazz_Pharmaceuticals_Logo.jpg